Exploitation of bacterial N-linked glycosylation to develop a novel recombinant glycoconjugate vaccine against Francisella tularensis.

Open biology

Volumn 3, Issue 5, 2013, Pages 130002-

  Cuccui, Jon ^a   Thomas, Rebecca M ^b   Moule, Madeleine G ^b   D'Elia, Riccardo V ^b   Laws, Thomas R ^b   Mills, Dominic C ^b   Williamson, Diane ^b   Atkins, Timothy P ^b   Prior, Joann L ^b   Wren, Brendan W ^b  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; DOLICHYL-DIPHOSPHOOLIGOSACCHARIDE - PROTEIN GLYCOTRANSFERASE; EXOTOXIN; GLYCOSYLTRANSFERASE; IMMUNOGLOBULIN G; MEMBRANE PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; O ANTIGEN; TOXA PROTEIN, PSEUDOMONAS AERUGINOSA; VACCINE; VIRULENCE FACTOR;

ANIMAL; BAGG ALBINO MOUSE; BLOOD; CAMPYLOBACTER JEJUNI; CHEMISTRY; ENZYMOLOGY; ESCHERICHIA COLI; FEMALE; FRANCISELLA TULARENSIS; GLYCOSYLATION; IMMUNOLOGY; METABOLISM; MOUSE; PHARMACEUTICS; PSEUDOMONAS AERUGINOSA; TULAREMIA;

ADP RIBOSE TRANSFERASES; ANIMALS; ANTIBODIES, BACTERIAL; BACTERIAL TOXINS; BACTERIAL VACCINES; CAMPYLOBACTER JEJUNI; ESCHERICHIA COLI; EXOTOXINS; FEMALE; FRANCISELLA TULARENSIS; GLYCOSYLATION; HEXOSYLTRANSFERASES; IMMUNOGLOBULIN G; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; O ANTIGENS; PSEUDOMONAS AERUGINOSA; TECHNOLOGY, PHARMACEUTICAL; TULAREMIA; VACCINES, CONJUGATE; VIRULENCE FACTORS;

EID: 84883140604     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.130002     Document Type: Article

References (0)